Royal Bank Of Canada Lexicon Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 11,399 shares of LXRX stock, worth $8,093. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,399

Previous 10,838 5.18%

Holding current value

$8,093

Previous $18,000 5.56%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.51 - $2.39 $847 - $1,340	561 Added 5.18%	11,399 $17,000
Q2 2024 Aug 14, 2024	BUY	$1.54 - $2.28 $13,351 - $19,767	8,670 Added 399.91%	10,838 $18,000
Q1 2024 Nov 05, 2024	SELL	$1.3 - $3.58 $11,271 - $31,038	-8,670 Reduced 80.0%	2,168 $5,000
Q1 2024 May 15, 2024	SELL	$1.3 - $3.58 $34,992 - $96,362	-26,917 Reduced 92.55%	2,168 $5,000
Q4 2023 Feb 14, 2024	BUY	$1.0 - $1.53 $15,307 - $23,419	15,307 Added 111.1%	29,085 $44,000
Q3 2023 Nov 14, 2023	BUY	$1.06 - $2.33 $6,223 - $13,679	5,871 Added 74.25%	13,778 $15,000
Q2 2023 Aug 14, 2023	BUY	$2.15 - $3.49 $6,981 - $11,332	3,247 Added 69.68%	7,907 $18,000
Q1 2023 May 15, 2023	SELL	$1.99 - $2.68 $15,840 - $21,332	-7,960 Reduced 63.07%	4,660 $11,000
Q4 2022 Feb 14, 2023	BUY	$1.8 - $2.56 $20,853 - $29,657	11,585 Added 1119.32%	12,620 $24,000
Q3 2022 Nov 14, 2022	BUY	$1.94 - $3.43 $223 - $394	115 Added 12.5%	1,035 $2,000
Q2 2022 Aug 15, 2022	SELL	$1.31 - $2.69 $5,097 - $10,466	-3,891 Reduced 80.88%	920 $2,000
Q1 2022 May 16, 2022	SELL	$1.95 - $3.89 $17,501 - $34,912	-8,975 Reduced 65.1%	4,811 $10,000
Q4 2021 Feb 14, 2022	BUY	$3.81 - $6.16 $27,085 - $43,791	7,109 Added 106.47%	13,786 $54,000
Q3 2021 Nov 15, 2021	BUY	$3.38 - $5.35 $5,042 - $7,982	1,492 Added 28.78%	6,677 $31,000
Q2 2021 Aug 16, 2021	BUY	$4.12 - $5.87 $21,362 - $30,435	5,185 New	5,185 $23,000

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $134M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Lexicon Pharmaceuticals, Inc. Transaction History